Prostatic Neoplasms Clinical Trials in Atlanta, Georgia

5 studies are recruiting for prostatic neoplasms in Atlanta, Georgia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

   The purpose of this study is to assess the efficacy and safety of opevesostat plus daily corticosteroids compared to alternative abiraterone acetate or enzalutamide in participants with Metastatic Castration-resistant Prostate Cancer (mCRPC) previously treated with one next-generation hormonal agen…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Northside Hospital-Northside Hospital Oncology Network ( Site 0100), Atlanta, Georgia

   Locations

   330 in total

   Run by

   Merck Sharp & Dohme LLC

   See if you can join NCT06136650 on ClinicalTrials.gov

2. A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

   Researchers are looking for new ways to treat metastatic castration-resistant prostate cancer (mCRPC). Researchers have designed a study medicine called ifinatamab deruxtecan (also called I-DXd or MK-2400) to treat mCRPC. The goal of this study is to learn if people who receive I-DXd live longer ov…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Emory University School of Medicine- Grady Campus ( Site 0103), Atlanta, Georgia

   Locations

   298 in total

   Run by

   Merck Sharp & Dohme LLC

   See if you can join NCT06925737 on ClinicalTrials.gov

3. Prostate Active Surveillance Study

   The Prostate Active Surveillance Study (PASS) is a research study for men who have chosen active surveillance as a management plan for their prostate cancer. Active surveillance is defined as close monitoring of prostate cancer with the offer of treatment if there are changes in test results. This …

   Stage

   Not phased

   Ages

   21 and older

   Site

   Emory University, Atlanta, Georgia

   Locations

   11 in total

   Run by

   University of Washington

   See if you can join NCT00756665 on ClinicalTrials.gov

4. A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

   The purpose of Parts 1, 2A, and 2B of the study is to determine the recommended regimen for Phase 2 (RP2Rs) of combination of JNJ-87189401 with JNJ-78278343 and the purpose of Part 2C of this study is to determine how safe the RP2R(s) of the combination of JNJ-87189401 and JNJ-78278343 is, with or …

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Emory University Winship Cancer Institute, Atlanta, Georgia

   Locations

   19 in total

   Run by

   Janssen Research & Development, LLC

   See if you can join NCT06095089 on ClinicalTrials.gov

5. Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection

   To determine the dose, safety, radiation dosimetry and efficacy of 177Lu-rhPSMA-10.1 in participants with PSMA-expressing metastatic castrate resistant prostate cancer.

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Emory University Hospital, Atlanta, Georgia

   Locations

   21 in total

   Run by

   Blue Earth Therapeutics Ltd

   See if you can join NCT05413850 on ClinicalTrials.gov